173 related articles for article (PubMed ID: 35787399)
21. BCL11B-Mediated Epigenetic Repression Is a Crucial Target for Histone Deacetylase Inhibitors in Cutaneous T-Cell Lymphoma.
Fu W; Yi S; Qiu L; Sun J; Tu P; Wang Y
J Invest Dermatol; 2017 Jul; 137(7):1523-1532. PubMed ID: 28288848
[TBL] [Abstract][Full Text] [Related]
22. deltaNp73 facilitates cell immortalization and cooperates with oncogenic Ras in cellular transformation in vivo.
Petrenko O; Zaika A; Moll UM
Mol Cell Biol; 2003 Aug; 23(16):5540-55. PubMed ID: 12897129
[TBL] [Abstract][Full Text] [Related]
23. High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR; Kim HT; Thomé C; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Glória AB; Chauffaille Mde L; Athayde M; Chiattone CS; Mito I; Bendlin R; Souza C; Bortolheiro C; Coelho-Silva JL; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
Blood; 2015 Nov; 126(20):2302-6. PubMed ID: 26429976
[TBL] [Abstract][Full Text] [Related]
24. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
Butler RM; McKenzie RC; Jones CL; Flanagan CE; Woollard WJ; Demontis M; Ferreira S; Tosi I; John S; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2019 Sep; 139(9):1975-1984.e2. PubMed ID: 30910759
[TBL] [Abstract][Full Text] [Related]
25. TP73, an under-appreciated player in non-Hodgkin lymphoma pathogenesis and management.
Hassan HM; Dave BJ; Singh RK
Curr Mol Med; 2014 May; 14(4):432-9. PubMed ID: 24730526
[TBL] [Abstract][Full Text] [Related]
26. TAp73 and ΔNp73 relative expression in Egyptian patients with lymphoid neoplasms.
Hamdy MSA; El-Saadany ZA; Makhlouf MM; Salama AI; Ibrahim NS; Gad AA
Tumori; 2017 May; 103(3):268-271. PubMed ID: 27103208
[TBL] [Abstract][Full Text] [Related]
27. BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.
Esmailzadeh S; Huang Y; Su MW; Zhou Y; Jiang X
Leukemia; 2015 Jun; 29(6):1402-13. PubMed ID: 25578476
[TBL] [Abstract][Full Text] [Related]
28. Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and ΔNp73 isoforms through ubiquitin ligase PIR2.
Taebunpakul P; Sayan BS; Flinterman M; Klanrit P; Gäken J; Odell EW; Melino G; Tavassoli M
Apoptosis; 2012 Aug; 17(8):762-76. PubMed ID: 22484480
[TBL] [Abstract][Full Text] [Related]
29. Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.
Nieto-Rementería N; Pérez-Yarza G; Boyano MD; Apraiz A; Izu R; Díaz-Pérez JL; Asumendi A
Br J Dermatol; 2009 Mar; 160(3):519-26. PubMed ID: 19067706
[TBL] [Abstract][Full Text] [Related]
30. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
Kato Y; Egusa C; Maeda T; Tsuboi R
J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
32. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
33. Functional Depletion of HSP72 by siRNA and Quercetin Enhances Vorinostat-Induced Apoptosis in an HSP72-Overexpressing Cutaneous T-Cell Lymphoma Cell Line, Hut78.
Fujii K; Idogawa M; Suzuki N; Iwatsuki K; Kanekura T
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681913
[TBL] [Abstract][Full Text] [Related]
34. ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria.
Schuster A; Schilling T; De Laurenzi V; Koch AF; Seitz S; Staib F; Teufel A; Thorgeirsson SS; Galle P; Melino G; Stremmel W; Krammer PH; Müller M
Cell Cycle; 2010 Jul; 9(13):2629-39. PubMed ID: 20581467
[TBL] [Abstract][Full Text] [Related]
35. DeltaNp73 transcription factors modulate cell survival and tumor development.
Ravni A; Tissir F; Goffinet AM
Cell Cycle; 2010 Apr; 9(8):1523-7. PubMed ID: 20372082
[TBL] [Abstract][Full Text] [Related]
36. TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma.
Müller M; Schilling T; Sayan AE; Kairat A; Lorenz K; Schulze-Bergkamen H; Oren M; Koch A; Tannapfel A; Stremmel W; Melino G; Krammer PH
Cell Death Differ; 2005 Dec; 12(12):1564-77. PubMed ID: 16195739
[TBL] [Abstract][Full Text] [Related]
37. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis.
Nihal M; Ahmad N; Wood GS
Cell Cycle; 2014; 13(4):632-40. PubMed ID: 24343700
[TBL] [Abstract][Full Text] [Related]
38. Romidepsin and Azacitidine Synergize in their Epigenetic Modulatory Effects to Induce Apoptosis in CTCL.
Rozati S; Cheng PF; Widmer DS; Fujii K; Levesque MP; Dummer R
Clin Cancer Res; 2016 Apr; 22(8):2020-31. PubMed ID: 26660520
[TBL] [Abstract][Full Text] [Related]
39. Novel cell adhesion/migration pathways are predictive markers of HDAC inhibitor resistance in cutaneous T cell lymphoma.
Andrews JM; Schmidt JA; Carson KR; Musiek AC; Mehta-Shah N; Payton JE
EBioMedicine; 2019 Aug; 46():170-183. PubMed ID: 31358475
[TBL] [Abstract][Full Text] [Related]
40. JAK inhibition synergistically potentiates BCL2, BET, HDAC, and proteasome inhibition in advanced CTCL.
Yumeen S; Mirza FN; Lewis JM; King ALO; Kim SR; Carlson KR; Umlauf SR; Surovtseva YV; Foss FM; Girardi M
Blood Adv; 2020 May; 4(10):2213-2226. PubMed ID: 32437546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
